Arch Therapeutics Inc (ARTH)

[ShareRunner]

Just rec’d this email response from ARTH

“.........
Thank you very much for your interest and investment in ARTH. Over the past several years, the company has made significant progress in the development of our product portfolio. We continue to strive to be able to bring our products to the market in a safe and effective manner. As we have indicated, these things take time, sometimes more than originally anticipated but our team is working diligently to file for a CE Mark for European approval, receive an appropriate 510(k) allowance in the US and commercialize AC5.

Again, your support is appreciated.

Best regards,

Rick
..............”